Clinical Trial Update: A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III trial evaluating lopinavir/ritonavir dosing according to WHO pediatric weight-band guidelines in HIV; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-12-21